文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Andrés Jerez
发表
NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy
J. Hernández-Rivas, T. Chen-Liang, H. Martínez-Banaclocha, 2023, Cell reports. Medicine.